Zydus Lifesciences (ZYDUSLIF IN) – Q1FY26 Result Update – Higher US sales to moderate – Accumulate
Published on 13 Aug 2025
-
Broking & Distribution
02266322222
- Wealth Management
-
Asset Management
02266322222
- Investment Banking
- Institutional Equities
- Securities Finance
